These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of proteomic and metabolic signatures associated with chemoresistance of human epithelial ovarian cancer. Wu W, Wang Q, Yin F, Yang Z, Zhang W, Gabra H, Li L. Int J Oncol; 2016 Oct; 49(4):1651-65. PubMed ID: 27511453 [Abstract] [Full Text] [Related]
6. Prognostic Significance of Preoperative Prognostic Nutritional Index in Epithelial Ovarian Cancer Patients Treated with Platinum-Based Chemotherapy. Miao Y, Li S, Yan Q, Li B, Feng Y. Oncol Res Treat; 2016 Oct; 39(11):712-719. PubMed ID: 27855385 [Abstract] [Full Text] [Related]
11. A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. Kang J, D'Andrea AD, Kozono D. J Natl Cancer Inst; 2012 May 02; 104(9):670-81. PubMed ID: 22505474 [Abstract] [Full Text] [Related]
14. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer. Pylväs-Eerola M, Karihtala P, Puistola U. BMC Cancer; 2015 Jul 02; 15():493. PubMed ID: 26134400 [Abstract] [Full Text] [Related]
16. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study. Elzarkaa AA, Sabaa BE, Abdelkhalik D, Mansour H, Melis M, Shaalan W, Farouk M, Malik E, Soliman AA. J Cancer Res Clin Oncol; 2016 May 02; 142(5):949-58. PubMed ID: 26762850 [Abstract] [Full Text] [Related]